Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Pan-KRAS Inhibitor Impedes Common KRAS Oncoproteins and Tumor Growth.

Cancer discovery - 4 Aug 2023

Abstract excerpt

A pan-KRAS inhibitor is selec-tive for the inactive state of multiple KRAS mutants, sparing other RAS isoforms.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Mutation
Share to Neoplasms
Share to Proto-Oncogene Proteins p21(ras)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37294122
DOI: 10.1158/2159-8290.CD-RW2023-090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Pan-KRAS Inhibitor Impedes Common KRAS Oncoproteins and Tumor Growth.PMID 37294122Read ↗

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth.Semantic proximity Read ↗

Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone.Semantic proximity Read ↗

Emerging landscape of KRAS inhibitors in cancer treatment.Semantic proximity Read ↗

Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.Semantic proximity Read ↗

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.Semantic proximity Read ↗

The current state of the art and future trends in RAS-targeted cancer therapies.Semantic proximity Read ↗

Targeting KRAS in cancer.Semantic proximity Read ↗

The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies.Semantic proximity Read ↗

KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance.Semantic proximity Read ↗

"Undruggable KRAS": druggable after all.Semantic proximity Read ↗

Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine.Semantic proximity Read ↗

Precision Targeting of KRAS-Mutant Cancers: Beyond G12C Toward G12D and Pan-RAS Therapeutic Strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.